Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS - Narrative (Details)

v3.23.2
INVESTMENTS - Narrative (Details)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Dec. 21, 2018
EUR (€)
Apr. 30, 2022
USD ($)
shares
Apr. 30, 2022
EUR (€)
shares
Dec. 31, 2020
USD ($)
Jan. 31, 2019
EUR (€)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
€ / shares
Dec. 01, 2020
Nov. 30, 2020
Sep. 30, 2020
EUR (€)
Sep. 30, 2019
USD ($)
shares
Sep. 30, 2019
EUR (€)
shares
Dec. 21, 2018
USD ($)
tranche
shares
Dec. 21, 2018
EUR (€)
tranche
€ / shares
shares
Summary of Investment Holdings [Line Items]                                      
Investment – Cansativa | $           $ 5,777,000   $ 5,777,000     $ 5,679,000                
Gain (loss) on investment | $           0 $ 6,851,000 0 $ 6,851,000                    
Equity method investments sold amount | $               0 2,498,000                    
Loss from investments | $           0 $ 0 0 64,000                    
Preferred Shares | Cansativa                                      
Summary of Investment Holdings [Line Items]                                      
Shares issued, price per share (Euro per share) | € / shares                       € 543.31              
Seed Financing Round | Cansativa                                      
Summary of Investment Holdings [Line Items]                                      
Shares issued (in shares) | shares                                   3,096 3,096
Investments, fully diluted pre-money valuation                                     € 8,500,000
Seed Financing Round | Preferred Shares | Cansativa                                      
Summary of Investment Holdings [Line Items]                                      
Shares issued, price per share (Euro per share) | € / shares                                     € 322,970
Cansativa                                      
Summary of Investment Holdings [Line Items]                                      
Percentage of interest held   7.60%                                  
Gain (loss) on investment | $       $ 211,000   $ 0   0                      
Sale of stock, number of shares issued/sold in transaction (in shares) | shares   1,586 1,586                                
Equity method investments sold amount     € 2,300,000                                
Equity method investment, gain recognized | $   $ 1,983,000                                  
Investments, additional gain (loss) recognized | $   $ 4,868,000                                  
Loss from investments | $               $ 0 $ 64,000                    
Cansativa | Cansativa, Employee Stock Ownership Plan (ESOP)                                      
Summary of Investment Holdings [Line Items]                                      
Shares issued (in shares) | shares   992                                  
Cansativa | Common Stock                                      
Summary of Investment Holdings [Line Items]                                      
Number of shares registered and fully paid-in capital (in shares) | shares                                   26,318 26,318
Cansativa | Preferred Shares | Series B Preferred Stock                                      
Summary of Investment Holdings [Line Items]                                      
Shares issued (in shares) | shares   10,184                                  
Cansativa | Seed Financing Round                                      
Summary of Investment Holdings [Line Items]                                      
Investments, net                                     € 7,000,000
Number of investment tranches | tranche                                   3 3
Percentage of interest held                                   10.53% 10.53%
Payments to acquire investments € 3,100       € 996,820                            
Share price (Euro per share) | € / shares                                     € 1.00
Investment – Cansativa                                   $ 1,075,000 € 999,920
Investments, initial amount                                     3,100
Investments, capital reverse payment                                     996,820
Investments, additional                               $ 722,000 € 650,000    
Investments, additional, shares (in shares) | shares                               2,138 2,138    
Investments, consideration transferred, net assets                               16.60% 16.60%    
Net assets                                 € 1,233,000    
Goodwill                                 € 1,122,000    
Cansativa | Seed Financing Round | Cansativa, Employee Stock Ownership Plan (ESOP)                                      
Summary of Investment Holdings [Line Items]                                      
Percentage of interest held                         15.80% 16.59%          
Cansativa | Seed Financing Round | Preferred Shares                                      
Summary of Investment Holdings [Line Items]                                      
Percentage of interest held       14.22%               14.22% 15.80%            
Cansativa | Tranche One                                      
Summary of Investment Holdings [Line Items]                                      
Investments, gross                                     1,000,000
Cansativa | Tranche One | Seed Financing Round                                      
Summary of Investment Holdings [Line Items]                                      
Investments, gross                                   $ 1,075,000 999,920
Cansativa | Tranche Two | Seed Financing Round                                      
Summary of Investment Holdings [Line Items]                                      
Investments, gross                             € 0       3,000,000
Gain (loss) on investment | $                   $ (370,000)                  
Cansativa | Tranche Three | Seed Financing Round                                      
Summary of Investment Holdings [Line Items]                                      
Investments, gross                                     € 3,000,000